Strauss Borrelli PLLC, a leading data breach law firm, is investigating OraSure Technologies, Inc. regarding a recent cybersecurity incident.
ABOUT ORASURE TECHNOLOGIES, INC.:
OraSure Technologies is a medical equipment manufacturing company based in Pennsylvania. Founded in 1987, OraSure Technologies, together with its wholly-owned subsidiaries, DNA Genotek, Diversigen, and Novosanis, provides its customers with end-to-end solutions that encompass tools, services and diagnostics.2 Additionally, OraSure Technologies and its family of companies are leaders in the development, manufacturing, and distribution of rapid diagnostic tests, sample collection and stabilization devices, and molecular services solutions designed to discover and detect critical medical conditions.2 Headquartered in Bethlehem, Pennsylvania, OraSure Technologies employs over 500 individuals.
WHAT HAPPENED?
On or about March 27, 2024, OraSure Technologies determined that it had experienced a cybersecurity incident in which an unauthorized third party gained access to portions of its information environment. On April 10, 2024, OraSure Technologies reported the incident in a Form 8-K filing with the United States Securities and Exchange Commission. According to the filing, OraSure Technologies’ investigation into the extent of the incident remains ongoing.
If you believe you have been impacted by the OraSure Technologies, Inc. cybersecurity incident:
We would like to speak with you about your rights and potential legal remedies in response to this data breach. Please fill out the form, below, or contact us at 872.263.1100 or sam@straussborrelli.com.
